Clinical Research Directory
Browse clinical research sites, groups, and studies.
Anti-obesity Pharmacotherapy and Inflammation
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Summary
This study evaluates the relationship between weight loss, circulating inflammatory markers and lipids from 24 patients before and after 6 months of pharmacotherapy as a standard of care for anti-obesity treatment
Official title: Pilot Study of the Effect of Weight Loss by Pharmacotherapy on Chronic Pro-tumor Inflammatory Cells
Key Details
Gender
All
Age Range
35 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2023-06-01
Completion Date
2026-02-20
Last Updated
2025-09-09
Healthy Volunteers
Not specified
Conditions
Interventions
Semaglutide
Medication for weight loss
Phentermine-Topiramate combination
Medication for weight loss
Phentermine
Medication for weight loss
Tirzepatide
Medication for weight loss
Topiramate
Medication for weight loss
Diethylpropion
Medication for weight loss
Naltrexone/Bupropion
Medication for weight loss
Liraglutide
Medication for weight loss
Locations (2)
LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO
New Orleans, Louisiana, United States
Ochsner Health System - Biospecimen
New Orleans, Louisiana, United States